Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | SeqCureNEO – Personalized cell therapy for all |
Description | SeqCureNEO is a cell therapy for curative treatment of advanced-stage cancer. Based on patient’s individual tumor mutations, no genetic |
Keywords | N/A |
WebSite | seqcureimmunology.com |
Host IP | 99.83.190.102 |
Location | United States |
Site | Rank |
US$910
Last updated: 2023-05-18 00:21:16
seqcureimmunology.com has Semrush global rank of 0. seqcureimmunology.com has an estimated worth of US$ 910, based on its estimated Ads revenue. seqcureimmunology.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, seqcureimmunology.com is safe to visit. |
Purchase/Sale Value | US$910 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$25 |
Yearly Ads Revenue | US$302 |
Daily Unique Visitors | 7 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
seqcureimmunology.com. | A | 3600 | IP: 99.83.190.102 |
seqcureimmunology.com. | A | 3600 | IP: 75.2.70.75 |
seqcureimmunology.com. | NS | 14400 | NS Record: ns01.one.com. |
seqcureimmunology.com. | NS | 14400 | NS Record: ns02.one.com. |
seqcureimmunology.com. | MX | 10800 | MX Record: 10 mx2.pub.mailpod2-cph3.one.com. |
seqcureimmunology.com. | MX | 10800 | MX Record: 10 mx1.pub.mailpod2-cph3.one.com. |
seqcureimmunology.com. | MX | 10800 | MX Record: 10 mx3.pub.mailpod2-cph3.one.com. |
seqcureimmunology.com. | TXT | 3600 | TXT Record: google-site-verification=q6naqwpYmp-ORowes33eEgTqOc4lFUHquDaIEfUPy80 |
Home About Contact Seq cure neo Advancing cancer immunotherapies. SeqCure Immunology is a Stockholm-based immunotherapy startup that develops SeqCureNEO, a curative, personalized cell therapy for treatment of advanced-stage cancer. About seqcure. Personalized cell therapy - for all cancers. SeqCure Immunology is a Stockholm-based company that develops SeqCure NEO , a personalized cell therapy product for the treatment of advanced-stage cancer. The SeqCure NEO cell product is created from the patient’s own immune cells, isolated from a blood sample. Through our proprietary culturing process, the cells are cultured and modified to react against the patient’s individual tumor mutations. No genetic engineering - only enrichment and strengthening of the weak anti-tumor immune response that already exists in the patient. SeqCure Immunology is currently seeking investors to fund the final pre-clinical developement of SeqCure NEO in preparation for its First-In-Man clinical trial. NEWS. |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Fri, 29 Apr 2022 09:29:58 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://seqcureimmunology.com/ HTTP/2 301 server: openresty date: Fri, 29 Apr 2022 09:29:59 GMT content-type: text/html content-length: 166 location: https://www.seqcureimmunology.com/ HTTP/2 200 server: openresty date: Fri, 29 Apr 2022 09:29:59 GMT content-type: text/html content-length: 27249 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-iad-kjyo7100152-IAD, cache-dub4333-DUB x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1651224599.394371,VS0,VE272 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
Domain Name: SEQCUREIMMUNOLOGY.COM Registry Domain ID: 2187419593_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.one.com Registrar URL: http://www.one.com Updated Date: 2021-11-16T08:07:07Z Creation Date: 2017-11-15T09:10:44Z Registry Expiry Date: 2022-11-15T09:10:44Z Registrar: One.com A/S Registrar IANA ID: 1462 Registrar Abuse Contact Email: abuse@one.com Registrar Abuse Contact Phone: +45 44451220 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: signedDelegation DNSSEC DS Data: 6811 13 2 48DEA3CB7D0A1E1DE9EB6DE368FDA56C5D22212EF8F351939C4834F59F377EEA >>> Last update of whois database: 2022-04-29T10:44:57Z <<< |